The document psad-sthlm3mri.pdf contains additional information on the secondary analysis in the article PSA density as a selection tool before MRI in prostate cancer screening: an analysis from the STHLM3-MRI randomized clinical trial (Björnebo et al., 2025).

Björnebo, L., Discacciati, A., Abbadi, A., Falagario, U.G., Chandra Engel, J., Vigneswaran, H.T., Jäderling, F., Grönberg, H., Eklund, M., Lantz, A., Nordström, T. (2025). PSA Density as a selection tool before MRI in prostate cancer screening: an analysis from the STHLM3-MRI randomized clinical trial. European Urology Focus